Clinical Trial Update: Olanzapine 2.5 vs 5 mg in Quadruplet Nausea/Vomiting Prophylaxis Before High-Dose Melphalan [Phase 3]

View source ↗

Summary

Phase 3 trial comparing two olanzapine dosing regimens (2.5 mg vs 5 mg) for nausea/vomiting prophylaxis before high-dose melphalan in autologous stem cell trans…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• olanzapine (olanzapine)

Snippet

Sponsor: Augusta University | Conditions: Multiple Myeloma, Autologous Stem Cell Transplantation | Phase 3 | Status: RECRUITING